Posted by Michael Wonder on 09 Apr 2017
The blame game on drug prices is getting dangerous
9 April 2017 - Manufacturers and payers all can lose if their squabbling leads the government to try to cut drug prices.
Drug manufacturers and the companies that pay for drugs are once again squabbling over why medicines are so expensive. That has the potential to upend the opaque and very profitable three-way relationship among pharmaceutical companies, insurers and pharmacy-benefit managers. Shares of all three are vulnerable.
